logo
Lexington council approves $540 million city budget. Here's what's in it

Lexington council approves $540 million city budget. Here's what's in it

Yahoo19 hours ago

The Lexington-Fayette Urban County Council unanimously passed a $540.2 million spending plan Thursday that includes money to improve sidewalks, millions for sewer system renovations and raises for most city employees.
The budget is for the fiscal year that begins July 1, and includes no tax increases.
It is the largest budget in the city's history, up 7% from two years ago, which was the first time the budget surpassed $500 million.
Mayor Linda Gorton's budget proposal included $28.2 million for improvements to the city sewer system; 3% raises for all non-union city employees; $19.2 million for street improvement projects, like connecting sidewalks and installing new traffic lights; and $3.4 million for new snow plows and street salt.
The council added nearly $1 million in additional spending. It added five positions, including an additional social worker for Lexington's Community Paramedicine Program and a deputy director of accounting.
The total cost to add that staff is $305,508.32. Most of that money comes from decreasing spending in other budgeted areas, like lowering the cost of allotted overtime for the fire department.
Gorton's budget included funding for 16.5 new positions. With council changes, the new budget has money for 21.5 new positions.
'I am always concerned when positions are added because the cost of salaries and benefits will continue in future budgets,' Gorton told the Herald-Leader.
Last year, Gorton vetoed personnel expenses added by the council, but that was ultimately overridden. Gorton doesn't plan to make any vetoes this year, spokeswoman Susan Straub said.
City council also added $500,000 to the budget for Lextran, the city's bus service, to run two pilot programs.
The downtown connector pilot program will run a bus on weekends from 4 p.m. through midnight connecting downtown to the distillery district.
A second pilot program will test micro-transit, a government-funded rideshare service — like Uber or Lyft — for trips where Lextran buses don't go.
The budget uses $18 million in bonding or borrowing, the smallest debt since the COVID pandemic. That includes $6.2 million for new city, police and road management vehicles, and $3 million to design a new training facility for the Lexington Fire Department.
The budget includes $14 million for paving, the same amount as last year's budget.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Where Could Air Canada Stock Be in 5 Years?
Where Could Air Canada Stock Be in 5 Years?

Yahoo

time22 minutes ago

  • Yahoo

Where Could Air Canada Stock Be in 5 Years?

Written by Andrew Button at The Motley Fool Canada Air Canada (TSX:AC) stock has been taking a beating in recent years. In 2020, in the early months of the COVID-19 pandemic, the stock fell all the way from $54 to $12, as the travel restrictions in that period caused the company's revenue to decline 80%. The company's stock later rallied when the first COVID vaccine was announced, but subsequently gave up the gains for reasons that are less clear. Today, Air Canada is in a much better place than it was in 2020. It's profitable. It has repaid much of its debt. Its revenue has recovered to its pre-COVID level and then some. Nevertheless, at around $19, AC stock is still nowhere near its pre-COVID stock price. What's going on here? There are a few lingering issues for Air Canada that have investors worrying about the stock, even though the underlying company is in a much better place than it was before the crash. The question is, why the apparent discrepancy? In this article, I will explore the reasons why Air Canada stock is still at a relatively low level and why I think it will be at a higher one in five years' time. One reason why some investors are concerned about Air Canada is because of the large amounts of capital expenditures (CAPEX) the company is undertaking in the next three years. CAPEX refers to spending on fixed assets like property, plant and equipment. In the case of an airline, it mainly refers to spending on new aircraft. Air Canada expects $3.4 billion in CAPEX in 2025, $4.3 billion in 2026, and $4.9 billion in 2027. After 2027, the CAPEX spend is expected to decline. The amounts of CAPEX above are fairly large. Notably, they exceed the company's past amounts of free cash flow, seeming to imply that Air Canada will be cash flow negative in the years ahead. Is this CAPEX such a big risk for Air Canada? In my opinion, no. Airplanes tend to be in service for decades, meaning that a lot of CAPEX now does not mean a lot of CAPEX in the future. Also, Air Canada's revenue has far surpassed levels seen in past years, so unprecedented CAPEX does not necessarily mean chronic cash burn. Overall, I don't think Air Canada's CAPEX is going to ruin the company. Another reason why people are concerned about Air Canada is because of Donald Trump's trade wars. Earlier this year, Trump slapped a 25% tariff on Canada, ostensibly to counter the flow of fentanyl into the United States. In response, many Canadians pledged to cancel vacations to the United States. Later, data collection firms reported that Canada-U.S. air travel did decline — one story claimed by as much as 70%. Air Canada said that it saw an impact but denied that its U.S. travel hours went down by 70%. Again, this strikes me as not that big of a risk. Canadians are most likely replacing U.S. travel with inter-provincial travel and overseas travel. Air Canada's most recent earnings release confirms this: revenue was stable year-over-year, and free cash flow was positive. On the whole, Air Canada looks like a bargain at 8.8 times earnings and 1.6 times operating cash flow. I think it will be worth more in five years' time than it is today. The post Where Could Air Canada Stock Be in 5 Years? appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Andrew Button has positions in Air Canada. The Motley Fool recommends Air Canada. The Motley Fool has a disclosure policy. 2025

From Dunnville to Niagara: Innovation, personalized care key to Hauser's Pharmacy longevity
From Dunnville to Niagara: Innovation, personalized care key to Hauser's Pharmacy longevity

Hamilton Spectator

time43 minutes ago

  • Hamilton Spectator

From Dunnville to Niagara: Innovation, personalized care key to Hauser's Pharmacy longevity

While it's not quite accurate to say Phil Hauser comes from a long line of pharmacists — unless you call second generation a long line — the profession is in his blood. 'I took my first steps in the back room of the pharmacy,' he said. That would be Hauser's Pharmacy. The Dunnville business was opened by his father Jim, who with his mother Bonnie took over a long-running pharmacy in 1980. Over the next 45 years, it has remained a fixture in that town. It gradually spread across southern Ontario — its first offshoot was in St. Catharines in 2014 when Hauser's opened in the new hospital. Last year, Hauser's opened its second location in the region, in the former CIBC building on Queen Street in Niagara Falls, a site it shares with a physician clinic. All the while, the pharmacy has maintained its independence and commitment to personalized care. 'We recognize every patient wants something different from their health-care provider,' said Hauser, who took over the family business in 2007 following his graduation from pharmacy school. 'Some people simply want their prescription filled fast and effectively, and we do that. Some people want more. Some people have a lot of questions about their conditions, some people want to question a lot of the information that they find online, and some people need that personal connection before discussing things that are otherwise very personal.' Hauser's Pharmacy current owner Phil Hauser in front of the prescription counter at the Dunnville store in 2021. At the time, Hauser's was preparing to administer COVID-19 vaccines. About the same time he took over the business, Hauser was elected to Ontario Pharmacists Association, for which he served six years. Among other things during that time, he advocated for an increased role of pharmacists in patient health care. Hauser's was one of 32 pharmacies involved in a pilot program in Ontario offering flu shots — something that has since been rolled out across the province. But the advocacy and innovation has been a constant thread in the family business, Hauser said. In the early 1980s, his mom called on the Health Ministry to have tobacco products removed from pharmacy shelves. 'Even though it was a significant source of income for pharmacies, it flew in the face of being a health-care provider, and providing something that we knew was poisonous or a detriment to people's health in the same breath,' Hauser said. Bonnie and Jim Hauser at a computer terminal in their Dunnville pharmacy. In the early 1980s, Hauser's Pharmacy was one of the first in Ontario to incorporate computerized patient prescription records. Also in the 1980s, Hauser's was also one of the first pharmacies to incorporate computer records to track patient prescriptions . 'It's something we take for granted today, but back then you were flipping through people's prescriptions and just making sure the refills were still valid,' he said. 'There wasn't the same level of continuous care that we're used to.' Hauser's launching a mobility and home health care division in 2014, Supper Services, its in-home private care division in 2021 and a remote dispensary operation for an underserved community in the Muskoka region in 2022. Hauser said this history of innovation and ability to provide a continuum of care for patients is what made the business an attractive choice for pharmacy partner with the now-named Marotta Family Hospital in St. Catharines. 'They recognized that our mission, our philosophy of bringing better patient care, was a key tenant that the NHS wanted to do, which was to guide the continuity of care for patients that were leaving outpatient clinics or were leaving the hospital altogether, and then making sure they had the proper transition into community care,' he said. This year, the pharmacy is marking its 45th anniversary at all nine of its stores with monthly giveaways, sales o throughout the year, children's colouring contests and rolling discounts. See its website, , to sign up to receive information or follow Hauser's on its social media channels. Hauser said their ability to remain independent lies in them striving to provide continual value for their patients. 'We want to provide the best level of health care,' he said. 'And I think that's not always something that's evident until you experience it. And when you experience it … my hope is when you come into a Hauser's Pharmacy and you notice a difference in the quality of care that that means something to you.'

RFK Jr. Appointee To CDC Advisory Committee Was A Paid Expert In Merck's Gardasil Lawsuit
RFK Jr. Appointee To CDC Advisory Committee Was A Paid Expert In Merck's Gardasil Lawsuit

Yahoo

time2 hours ago

  • Yahoo

RFK Jr. Appointee To CDC Advisory Committee Was A Paid Expert In Merck's Gardasil Lawsuit

Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC's Advisory Committee on Immunization Practices on Wednesday, including several anti-vaccine proponents, after dismissing all 17 existing advisers. Kennedy justified the overhaul to 're-establish public confidence in vaccine science,' claiming, without providing specific evidence, that prior Biden-appointed members had conflicts of interest. The new eight-member committee represents the minimum allowed under ACIP's founding charter. Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Martin Kulldorff, a biostatistician and epidemiologist, was among eight individuals selected by Kennedy to join the Advisory Committee on Immunization Practices (ACIP). Kulldorff has been an outspoken critic of COVID-19 lockdowns and vaccine mandates. His appointment has also raised questions due to his paid involvement in litigation against a major vaccine manufacturer, according to Reuters. Citing court records, Reuters notes that Kulldorff served as an expert witness in lawsuits against Merck & Co Inc (NYSE:MRK) over its Gardasil vaccine, which is used to prevent cancers caused by the human papillomavirus (HPV). The plaintiff accused the pharmaceutical company of not properly disclosing the vaccine's risks. Gardasil was approved in the U.S. in 2006 after going through clinical trials to prove its safety and a deposition in October, Kulldorff acknowledged that he had been paid $400 an hour for his work on the case and had billed approximately $33,000 through September. He also received a $4,000 retainer in connection with the North Carolina lawsuit, which was part of a broader legal effort encompassing about 200 related cases. In March, a federal judge ruled in favor of Merck in that particular case. Kulldorff's paid role as a litigation consultant could conflict with ACIP's established rules. According to the committee's guidelines, members are prohibited from serving as paid expert witnesses or litigation consultants in cases involving vaccine manufacturers while actively serving on the panel. Gardasil/Gardasil 9 sales declined 41% to $1.33 billion in the first quarter of 2025, primarily due to lower demand in China, partially offset by higher demand in most international regions, particularly in Japan, and higher pricing and demand in the U.S. Excluding China, sales grew 14%, or 16%, excluding the impact of foreign exchange. Read Next: Are you rich? Here's what Americans think you need to be considered wealthy. Bezos' Favorite Real Estate Platform Launches A Way To Ride The Ongoing Private Credit Boom Photo: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article RFK Jr. Appointee To CDC Advisory Committee Was A Paid Expert In Merck's Gardasil Lawsuit originally appeared on Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store